Zytiga 250 mg (Abiraterone acetate 250 mg per tablet) by Janssen.
Indications: Metastatic castration-resistant and high-risk hormone-sensitive prostate cancer, with prednisone/prednisolone.
Administration: Oral: 1000 mg once daily on an empty stomach.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Janssen |
| Active ingredient | Abiraterone acetate 250 mg per tablet — CYP17 inhibitor. |
| Strength & pack | 120 tablets. |
| Form | Tablets |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |